Arpita Surkunte, MD
Physician
GLP-1 clinic in Chandler · Telehealth available
2390 W Ray Rd, #1, Chandler, AZ 85224
What this provider offers
New Viva MD is a medical weight-loss clinic in Chandler, AZ. The clinic lists Ozempic, Wegovy, Zepbound, Mounjaro, Semaglutide, Tirzepatide, Liraglutide, and Saxenda among its GLP-1 services.
Listing details last checked July 2026 against the clinic's own site. How we verify.
New Viva MD is one of 2 GLP-1 clinics listed in Chandler. It is the only one in Chandler naming Liraglutide, Zepbound, and Saxenda, which is worth knowing if that is what you came for. One of the others in Chandler publish a program price, which this one does not.
Care team
Physician
Patient experience
Editorial scores and paid placement do not affect these reviews.
Drawn from what this listing does and does not tell you, so the first call settles the total cost and who provides the care.
Common questions
New Viva MD names Semaglutide, Tirzepatide, Liraglutide, Ozempic, Wegovy, Mounjaro, Zepbound, and Saxenda on its own site. That is what the clinic advertises, not a guarantee of supply, and which medication you start on is decided at the evaluation.
New Viva MD sees patients at its Chandler location and its site describes video visits as well. Ask which appointments have to happen in person, since the first evaluation often does.
Arpita Surkunte, MD is named as a prescriber on the clinic's site, not yet matched to a licensing registry.
New Viva MD does not publish a program price. Ask for the total first-month cost and what it becomes after, and whether labs and follow-up visits sit inside that figure or outside it.
2390 W Ray Rd, #1, Chandler, AZ 85224. It is one of 2 GLP-1 clinics listed in Chandler.
Nearby
Worth comparing before booking, since what a program includes and what it charges after the first month differ more between clinics than the medication does.
See every GLP-1 clinic in ChandlerBy medication
Worth reading before you call
Chosen from what this listing names: its medications, how it sees patients, and what it publishes about price.